Welcome to our dedicated page for Marpai news (Ticker: MRAI), a resource for investors and traders seeking the latest updates and insights on Marpai stock.
Marpai, Inc. reports recurring developments in healthcare technology, third-party administration and pharmacy benefit management services for employers that directly fund employee health benefits. The company operates subsidiaries that provide TPA, PBM and value-oriented health plan services, including the MarpaiRx pharmacy benefit platform and the Marpai Saves initiative.
News about MRAI commonly covers MarpaiRx client wins, marketing collaborations, network access arrangements with providers such as Aetna and Cigna, financial results, operating efficiency initiatives and leadership changes tied to its health benefits administration business.
Marpai (Nasdaq: MRAI), a deep learning technology company, will host a conference call on March 31, 2022, at 8:30 a.m. ET to discuss its fourth quarter and full year financial results for 2021. The results will be reported after trading on March 30, 2022. Marpai aims to transform third-party administration in the self-funded health insurance market, leveraging AI to optimize health plan services, which potentially impacts over $1T in annual healthcare claims. The call provides an opportunity to gain insights into Marpai's operational and financial performance.
Marpai, Inc. (Nasdaq: MRAI) has appointed Lutz Finger, former Google Group Product Manager in healthcare analytics, as its President of Product and Development. Finger, with over 20 years of experience, will spearhead product management and development strategies aimed at enhancing the efficiency of Marpai's services in the $22B Third-Party Administrator market. His leadership is expected to drive innovative, AI-powered solutions that lower healthcare costs and improve health outcomes for members, starting February 28, 2022.
Marpai, Inc. (NASDAQ: MRAI) announced preliminary fourth-quarter 2021 revenues expected between $5.7 million and $5.9 million, surpassing prior guidance of $5.6 million to $5.8 million, indicating approximately 19% to 23% growth from Q3 2021. As of December 31, 2021, the company reported $19.2 million in cash and cash equivalents. Full audited financial results are anticipated by March 31, 2022. Marpai offers AI-driven TPA services in the $22 billion market, improving healthcare management for employers and impacting over $1 trillion in healthcare claims annually.
Marpai, Inc. (Nasdaq: MRAI), a deep learning technology company, has launched AI-powered services to improve employer health plans, aiming to reduce health claims costs and enhance care quality for over 156 million Americans. The self-funded employer market, representing more than $1 trillion in claims annually, is targeted for these services. CEO Edmundo Gonzalez states the goal is to slash costs in half using advanced AI, supported by tech-enabled offerings like Marpai Cares and the MyMarpai SMART App. Marpai's innovative approach promises significant changes in handling rising health plan expenses.
Marpai, Inc. (Nasdaq: MRAI) has launched Marpai Cares, an AI-powered proactive health service aimed at enhancing patient outcomes in self-funded health insurance. This service leverages deep learning to identify and address health issues linked to chronic diseases like diabetes and cardiovascular problems. Licensed clinicians from MedWatch assist members in navigating their care journeys. Marpai serves over 40,000 members across 60+ employers, positioning itself as a leading alternative in the $1T self-funded health insurance market.
Marpai, Inc. (NASDAQ: MRAI), a leader in deep learning technology for self-funded health insurance, will feature CEO Edmundo Gonzalez on The RedChip Money Report® airing on Bloomberg TV on January 8 at 7 p.m. ET. This engagement offers exposure to an audience of approximately 73 million households across the U.S. Marpai strives to reduce healthcare costs and improve outcomes through AI innovations, currently serving over 60 companies and 40,000 members nationwide. Forward-looking statements in the release suggest potential risks concerning market conditions and business growth.
Marpai, Inc. (Nasdaq: MRAI) is expanding into the education market by establishing a center of excellence to enhance health plan services for school districts. Currently, Marpai is serving four Texas school districts, impacting 39 schools. The company's AI-driven services aim to improve member health and reduce costs, utilizing predictive deep learning to guide members to quality care and prevent costly health events. Collaborating with Synolo and USEBSG, Marpai's initiative emphasizes a proactive approach to healthcare for educators and their families.
Marpai, Inc. (NASDAQ: MRAI) announced that its management and directors have collectively purchased $1.1 million in common stock. Board member Damien Lamendola increased his holdings, acquiring 225,000 warrants at $4 per share, injecting an additional $900,000 into the company. Notable purchases include 25,000 shares by Chairman Yaron Eitan and 17,500 shares by CEO Edmundo Gonzalez, with prices ranging from $4.17 to $4.42 per share. These actions reflect confidence in Marpai's AI-driven solutions in the self-funded health insurance market.
Marpai, Inc. (NASDAQ: MRAI) reported financial results for Q3 2021, achieving net revenue of approximately $4.8 million, marking a 36% sequential increase over the first half of 2021. Revenue growth reflects a rise in covered employees by 23% to 25,136. Operating expenses surged to $9.5 million, resulting in a net loss of $4.8 million. The company also closed its IPO, generating $28.75 million in gross proceeds. For Q4 2021, Marpai anticipates revenue guidance of $5.6 million to $5.8 million, indicating 17% to 21% sequential growth.
Marpai, Inc. (Nasdaq: MRAI), a deep learning technology firm in the self-funded health insurance market, has scheduled a conference call for December 9 at 4:15 p.m. ET to discuss its third quarter financial results for the period ending September 30, 2021. The call will follow the release of the Q3 results after market close. Marpai aims to enhance healthcare cost management and health outcomes through advanced predictive technologies. Interested parties can access a replay of the call until December 23 and a recording of the webcast will be available for 90 days on their investor relations site.